Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure

European Journal of Heart Failure

Volumn 9, Issue 9, 2007, Pages 910-916

  Gustafsson, Finn ^a   Schou, Morten ^b   Videbæk, Lars ^c   Nielsen, Tonny ^d   Ulriksen, Hans ^e   Markenvard, John ^f   Svendsen, Tage Lysbo ^g   Ryde, Henrik ^h   Vigholt, Else ⁱ   Hildebrandt, Per ^j  

^a Rigshospitalet   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d Esbjerg Central Hospital   (Denmark)

^e SKIVE REGIONAL HOSPITAL   (Denmark)

^f Fredericia Sygehus   (Denmark)

^g HOLBÆK HOSPITAL   (Denmark)

^h SLAGELSE HOSPITAL   (Denmark)

ⁱ HORSENS REGIONAL HOSPITAL   (Denmark)

^j ROSKILDE HOSPITAL   (Denmark)

more..

Author keywords

Beta blocker; Case management; Ejection fraction; Heart failure clinic

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; METOPROLOL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RELEASE; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NURSE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TREATMENT FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; DENMARK; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NURSING CARE; SYSTOLE; TREATMENT FAILURE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548240143     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.05.008     Document Type: Article

References (37)

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
3. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
4. Komajda M., Follath F., Swedberg K., et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24 (2003) 464-474
5. Mehta P.A., McDonagh S., Poole-Wilson P.A., et al. Heart failure in a district general hospital: are target doses of beta-blockers realistic?. QJM 97 (2004) 133-139
6. Tandon P., McAlister F.A., Tsuyuki R.T., et al. The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes. Arch Intern Med 164 (2004) 769-774
7. Lenzen M.J., Boersma E., Reimer W.J., et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 26 (2005) 2706-2713
8. Gustafsson F., and Arnold J.M. Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J 25 (2004) 1596-1604
9. Roccaforte R., Demers C., Baldassarre F., et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 7 (2005) 1133-1144
10. Erratum in:. Eur J Heart Fail 8 (2006) 223-224
11. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
12. Jaarsma T., Tan B., Bos R.J., and van Veldhuisen D.J. Heart failure clinics in the Netherlands in 2003. Eur J Cardiovasc Nurs 3 (2004) 271-274
13. Gustafsson F., Ulriksen H., Villadsen H., et al. Prevalence and characteristics of heart failure clinics in Denmark-design of the Danish heart failure clinics network. Eur J Heart Fail 7 (2005) 283-284
14. Stromberg A., Martensson J., Fridlund B., and Dahlstrom U. Nurse-led heart failure clinics in Sweden. Eur J Heart Fail 3 (2001) 139-144
15. Jaarsma T., Stromberg A., De Geest S., et al. Heart failure management programmes in Europe. Eur J Cardiovasc Nurs 5 (2006) 197-205
16. Andersen M.K., Markenvard J.D., Schjott H., et al. Effects of a nurse-based heart failure clinic on drug utilization and admissions in a community hospital setting. Scand Cardiovasc J 39 (2005) 199-205
17. Galatius S., Gustafsson F., Nielsen P.H., et al. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 144 (2002) E2
18. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
19. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
20. Franciosa J.A., Massie B.M., Lukas M.A., et al. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry. Am Heart J 148 (2004) 718-726
21. Krum H., Ninio D., and MacDonald P. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Heart 84 (2000) 615-619
22. Maggioni A.P., Sinagra G., Opasich C., et al. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 89 (2003) 299-305
23. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334 (1996) 1349-1355
24. LaPointe N.M., DeLong E.R., Chen A., et al. Multifaceted intervention to promote beta-blocker use in heart failure. Am Heart J 151 (2006) 992-998
25. Ansari M., Shlipak M.G., Heidenreich P.A., et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation 107 (2003) 2799-2804
26. Butler J., Khadim G., Belue R., et al. Tolerability to beta-blocker therapy among heart failure patients in clinical practice. J Card Fail 9 (2003) 203-209
27. Opasich C., Boccanelli A., Cafiero M., et al. Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: results of the BRING-UP 2 Study. Eur J Heart Fail (2006)
28. Gattis W.A., O'Connor C.M., Gallup D.S., et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534-1541
29. Estep J.D., Mehta S.K., Uddin F., et al. Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials. Am Heart J 148 (2004) 958-963
30. Witham M.D., Gillespie N.D., and Struthers A.D. Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Age Ageing 33 (2004) 467-472
31. Baxter A.J., Spensley A., Hildreth A., et al. Beta blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 88 (2002) 611-614
32. Gupta R., Tang W.H., and Young J.B. Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. Am Heart J 147 (2004) 79-83
33. Owen A. Experience of commencing Carvedilol in elderly patients with heart failure in a routine outpatient clinic. Eur J Heart Fail 2 (2000) 287-289
34. Deedwania P.C., Giles T.D., Klibaner M., et al. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J 149 (2005) 159-167
35. Rouleau J.L., Roecker E.B., Tendera M., et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 43 (2004) 1423-1429
36. Jaarsma T., Van Der Wal M.H., Hogenhuis J., et al. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail 6 (2004) 227-233
37. Ekman I., and Swedberg K. Home-based management of patients with chronic heart failure-focus on content not just form!. Eur Heart J 23 (2002) 1323-1325